Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study.
Altieri B, Sbiera S, Herterich S, De Francia S, Della Casa S, Calabrese A, Pontecorvi A, Quinkler M, Kienitz T, Mannelli M, Canu L, Angelousi A, Chortis V, Kroiss M, Terzolo M, Fassnacht M, Ronchi CL. Altieri B, et al. Among authors: calabrese a. Cancers (Basel). 2020 Feb 4;12(2):359. doi: 10.3390/cancers12020359. Cancers (Basel). 2020. PMID: 32033200 Free PMC article.
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment.
Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A, Malandrino P, Saba L, Altieri B, Della Casa S, Perotti P, Berchialla P, De Filpo G, Canu L, Loli P, Reimondo G, Terzolo M. Puglisi S, et al. Among authors: calabrese a. J Clin Med. 2019 Nov 2;8(11):1850. doi: 10.3390/jcm8111850. J Clin Med. 2019. PMID: 31684071 Free PMC article.
New perspectives for mitotane treatment of adrenocortical carcinoma.
Puglisi S, Calabrese A, Basile V, Pia A, Reimondo G, Perotti P, Terzolo M. Puglisi S, et al. Among authors: calabrese a. Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101415. doi: 10.1016/j.beem.2020.101415. Epub 2020 Mar 5. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32179008 Free article. Review.
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma.
Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Altieri B, Della Casa S, Loli P, Pivonello R, De Martino MC, Canu L, Russo M, Badalamenti G, Torlontano M, Stigliano A, Ferraù F, Arnaldi G, Saba L, Quirino A, Perotti P, Berchialla P, Terzolo M. Puglisi S, et al. Among authors: calabrese a. Cancers (Basel). 2020 Mar 20;12(3):740. doi: 10.3390/cancers12030740. Cancers (Basel). 2020. PMID: 32245135 Free PMC article.
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question.
Basile V, Puglisi S, Altieri B, Canu L, Libè R, Ceccato F, Beuschlein F, Quinkler M, Calabrese A, Perotti P, Berchialla P, Dischinger U, Megerle F, Baudin E, Bourdeau I, Lacroix A, Loli P, Berruti A, Kastelan D, Haak HR, Fassnacht M, Terzolo M. Basile V, et al. Among authors: calabrese a. J Pers Med. 2021 Apr 4;11(4):269. doi: 10.3390/jpm11040269. J Pers Med. 2021. PMID: 33916613 Free PMC article.
338 results